Estimates of the lifetime direct costs of treatment for metastatic breast cancer

Value in Health

Volumn 3, Issue 1, 2000, Pages 23-30

  Berkowitz, Noah ^a   Gupta, Sanjay ^b   Silberman, George ^a,c  

^a IMPATH Inc ^*  (United States)

^b HOFFMANN LA ROCHE INC   (United States)

^c IMPATH Inc   (United States)

Author keywords

Breast cancer; Costs; Modeling; Survival

Indexed keywords

ARTICLE; BREAST CANCER; CANCER INCIDENCE; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE UTILIZATION; LIFE EXPECTANCY; METASTASIS; PRIORITY JOURNAL; SECONDARY PREVENTION; UNITED STATES;

EID: 0034014219     PISSN: 10983015     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4733.2000.31003.x     Document Type: Article

References (14)

1. US National Cancer Institute. SEER Cancer Statistic Review. 1973–1995, Section 4.
2. J-M Berthelot C Le Petit W Flanagan Use of longitudinal data in health policy simulation models 1997 Proceedings of the Government Statistics Section, American Statistical Association Ottawa, Canada 120 129
3. KM Gorey EJ Holoway G Fehringer An international comparison of cancer survival: Toronto, Ontario and Detroit, Michigan Metropolitan Areas Am J Public Health 87 7 1997 1156 1163
4. D Keller EA Peterson G Silberman Survival rates for four forms of cancer in the US and Ontario Am J Public Health 87 7 1997 1164 1167
5. I Henderson The nature of the benefit Cancer Treatment Res 60 1992 57 68
6. S Finkler The distinction between cost and charges Ann Int Med 96 1982 102 109
7. MC Wolfson POHEM—a framework for understanding and modeling the health of human populations World Health Stat Quart 47 1994 157 176
8. Will BP, Le Petit C, Berthelot J-M, et al. The lifetime cost of treating breast cancer in Canada. Eur J Cancer. In press 2000.
9. M Keyser J Crawley G Goldberg M Shaw Gastroesophageal Reflux Disease in a managed care setting: professional, facility, and pharmacy charges J Managed Care Pharmacy 4 1998 64 70
10. MC Weinstein JE Siegel MR Gold Recommendations of the panel on cost-effectiveness in health and medicine JAMA 276 1996 1253 1258
11. SH Taplin W Barlow N Urban MT Mandelson Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care J Nat Cancer Inst 87 6 1995 417 426
12. BH Fireman CP Quesenberry CP Somkin Cost of care for cancer in a health maintenance organization Health Care Financ Rev 18 1997 51 76
13. MS Baker LG Kessler N Urban RC Smucker Estimating the treatment costs of breast and lung cancer Med Care 29 1 1991 40 49
14. MA Richards S Braysher WM Gregory RD Rubens Advanced breast cancer: use of resources and cost implications Br J Cancer 67 1993 856 860